Skip to main content
logo
Titan Pharmaceuticals, Inc. (TTNP)
Oct 2, 2025 - TTNP was delisted (reason: merged into BTTC).
4.610
-0.180 (-3.76%)
Inactive · Last trade price on Oct 1, 2025

Titan Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-2.81-4.71-5.57-10.21-8.78-18.24
Depreciation & Amortization
-0.010.110.20.220.29
Stock-Based Compensation
--1.041.451.540.01
Other Adjustments
--0-1.760-0.67-0.28
Change in Receivables
0.041.05-0.010.080.770.19
Changes in Inventories
---0.190.040.29
Changes in Accounts Payable
-0.14-0.15-0.48-0.75-1.191.1
Changes in Accrued Expenses
0.04-0.24-0.420.8-0.29-0.95
Changes in Unearned Revenue
--0.01-0.18-0.10.3-
Changes in Other Operating Activities
0.120.170.180.160.160.39
Operating Cash Flow
-2.75-3.88-7.09-8.18-7.9-17.2
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
---0--0.02-0.54
Sale of Property, Plant & Equipment
--0.73---
Investing Cash Flow
--0.73--0.02-0.54

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Long-Term Debt Issued
--0.75--0.65
Long-Term Debt Repaid
---0.25---1.6
Net Long-Term Debt Issued (Repaid)
--0.5---0.95
Issuance of Common Stock
---4.988.8418.88
Net Common Stock Issued (Repurchased)
---4.988.8418.88
Issuance of Preferred Stock
1.6-9.5---
Net Preferred Stock Issued (Repurchased)
1.6-9.5---
Other Financing Activities
-0.14-0.06----
Financing Cash Flow
1.46-0.06104.988.8417.93

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
-1.29-3.943.64-3.20.920.19
Beginning Cash & Cash Equivalents
4.096.773.136.335.415.22
Ending Cash & Cash Equivalents
2.82.836.773.136.335.41

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
-2.75-3.88-7.09-8.18-7.92-17.74
Free Cash Flow Growth
------
Free Cash Flow Per Share
-2.85-4.32-9.43-12.18-16.28-94.05
Levered Free Cash Flow
0.02-0.22-0.30.5-0.79-0.36
Unlevered Free Cash Flow
0.02-0.22-0.80.5-0.790.58
SEC Filings: 10-K · 10-Q